Pataky R E, Baliski C R
Canadian Centre for Applied Research in Cancer Control, BC Cancer Agency, Vancouver.
Surgical Oncology, Sindi Ahluwalia Hawkins Centre for the Southern Interior, BC Cancer Agency, Kelowna, University of British Columbia, Vancouver, BC; Department of Surgery, University of British Columbia, Vancouver, BC.
Curr Oncol. 2016 Oct;23(5):314-321. doi: 10.3747/co.23.2989. Epub 2016 Oct 25.
Breast-conserving surgery (bcs) is the preferred surgical approach for most patients with early-stage breast cancer. Frequently, concerns arise about the pathologic margin status, resulting in an average reoperation rate of 23% in Canada. No consensus has been reached about the ideal reoperation rate, although 10% has been suggested as a target. Upon undergoing reoperation, many patients choose mastectomy and breast reconstruction, which add to the morbidity and cost of patient care. We attempted to identify the cost of reoperation after bcs, and the effect that a reduction in the reoperation rate could have on the B.C. health care system.
A decision tree was constructed to estimate the average cost per patient undergoing initial bcs with two reoperation frequency scenarios: 23% and 10%. The model included the direct medical costs from the perspective of the B.C. health care system for the most common surgical treatment options, including breast reconstruction and postoperative radiation therapy.
Costs ranged from a low of $8,225 per patient with definitive bcs [95% confidence interval (ci): $8,061 to $8,383] to a high of $26,026 for reoperation with mastectomy and delayed reconstruction (95% ci: $23,991 to $28,122). If the reoperation rate could be reduced to 10%, the average saving would be $1,055 per patient undergoing attempted bcs (95% ci: $959 to $1,156). If the lower rate were to be achieved in British Columbia, it would translate into a savings of $1.9 million annually.
The implementation of initiatives to reduce reoperation after bcs could result in significant savings to the health care system, while potentially improving the quality of patient care.
保乳手术(BCS)是大多数早期乳腺癌患者首选的手术方式。病理切缘状态常引发担忧,导致加拿大的平均再次手术率为23%。尽管有人建议将10%作为目标,但对于理想的再次手术率尚未达成共识。许多患者在接受再次手术后选择乳房切除术和乳房重建,这增加了患者护理的发病率和成本。我们试图确定保乳手术后再次手术的成本,以及再次手术率降低对不列颠哥伦比亚省医疗保健系统可能产生的影响。
构建决策树,以估计在两种再次手术频率情况下(23%和10%)接受初次保乳手术的每位患者的平均成本。该模型纳入了不列颠哥伦比亚省医疗保健系统视角下最常见手术治疗方案的直接医疗成本,包括乳房重建和术后放射治疗。
成本范围从确定保乳手术时每位患者的8225美元(95%置信区间[CI]:8061美元至8383美元)到乳房切除和延迟重建的再次手术时的26026美元(95%CI:23991美元至28122美元)不等。如果再次手术率能够降至10%,那么每位尝试保乳手术的患者平均可节省1055美元(95%CI:959美元至1156美元)。如果在不列颠哥伦比亚省实现较低的再次手术率,每年将节省190万美元。
实施旨在降低保乳手术后再次手术率的举措可能会为医疗保健系统带来显著节省,同时有可能提高患者护理质量。